Bradley Wertheim is a Respiratory physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 39 publications with 921 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Brigham And Womens Hospital
Boston, MA 021156110
Telephone
617-732-6770Registry record last updated 27 Jun 2017.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
67.4%Anticholinergic34.1%Incruse Ellipta100%Part D<11 patientsCorticosteroid23%Breo Ellipta100%Part D<11 patients+ 1 more class in this area
Anti-infectives
15.6%Macrolide Antimicrobial15.6%Azithromycin100%Part D<11 patientsGenitourinary & hormones
8.9%Phosphodiesterase 5 Inhibitor8.9%Sildenafil Citrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Endothelial Inflammation, Src Kinase Dysregulation, and Fibrosis in Early Pulmonary Arterial Hypertension
Brigham and Women'S Hospital
FY2026$739,659R01HL176637 - Endothelial Inflammation, Src Kinase Dysregulation, and Fibrosis in Early Pulmonary Arterial Hypertension
Brigham and Women'S Hospital
FY2025$800,962R01HL176637 - Endothelial Proline Utilization in Pulmonary Arterial Hypertension
Brigham and Women'S Hospital
FY2025$131,485R03HL172985
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spatial Transcriptomic Analysis of Familial Pulmonary Arterial Hypertension Due to a Novel KDR Mutation
American Journal of Respiratory and Critical Care Medicine
2025 - Branched-chain α-ketoacids aerobically activate HIF1α signalling in vascular cells
Nature Metabolism
2024 - Branched chain α-ketoacids aerobically activate HIF1α signaling in vascular cells
bioRxiv (Cold Spring Harbor Laboratory)
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”